377 related articles for article (PubMed ID: 18511846)
21. The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation.
Calkin AC; Giunti S; Sheehy KJ; Chew C; Boolell V; Rajaram YS; Cooper ME; Jandeleit-Dahm KA
Diabetologia; 2008 Sep; 51(9):1731-40. PubMed ID: 18594792
[TBL] [Abstract][Full Text] [Related]
22. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse.
Thomas MC; Pickering RJ; Tsorotes D; Koitka A; Sheehy K; Bernardi S; Toffoli B; Nguyen-Huu TP; Head GA; Fu Y; Chin-Dusting J; Cooper ME; Tikellis C
Circ Res; 2010 Oct; 107(7):888-97. PubMed ID: 20671240
[TBL] [Abstract][Full Text] [Related]
23. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
Lu Z; Zhang X; Li Y; Jin J; Huang Y
J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
[TBL] [Abstract][Full Text] [Related]
24. Sitagliptin attenuates arterial calcification by downregulating oxidative stress-induced receptor for advanced glycation end products in LDLR knockout mice.
Lin CP; Huang PH; Chen CY; Wu MY; Chen JS; Chen JW; Lin SJ
Sci Rep; 2021 Sep; 11(1):17851. PubMed ID: 34497344
[TBL] [Abstract][Full Text] [Related]
25. Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis.
Koulis C; Kanellakis P; Pickering RJ; Tsorotes D; Murphy AJ; Gray SP; Thomas MC; Jandeleit-Dahm KA; Cooper ME; Allen TJ
Clin Sci (Lond); 2014 Oct; 127(7):485-97. PubMed ID: 24724734
[TBL] [Abstract][Full Text] [Related]
26. RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation.
Li Y; Liu S; Zhang Z; Xu Q; Xie F; Wang J; Ping S; Li C; Wang Z; Zhang M; Huang J; Chen D; Hu L; Li C
PLoS One; 2012; 7(4):e35016. PubMed ID: 22496883
[TBL] [Abstract][Full Text] [Related]
27. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice.
Kislinger T; Tanji N; Wendt T; Qu W; Lu Y; Ferran LJ; Taguchi A; Olson K; Bucciarelli L; Goova M; Hofmann MA; Cataldegirmen G; D'Agati V; Pischetsrieder M; Stern DM; Schmidt AM
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):905-10. PubMed ID: 11397695
[TBL] [Abstract][Full Text] [Related]
28. Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway.
Zhou F; Tan Y; Chen XH; Wu FL; Yang DJ; Zhang XW; Wu XM; Deng YQ
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(4):1142-1149. PubMed ID: 29509268
[TBL] [Abstract][Full Text] [Related]
29. The receptor for advanced glycation end products impairs collateral formation in both diabetic and non-diabetic mice.
Hansen LM; Gupta D; Joseph G; Weiss D; Taylor WR
Lab Invest; 2017 Jan; 97(1):34-42. PubMed ID: 27869797
[TBL] [Abstract][Full Text] [Related]
30. A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes.
Tekabe Y; Luma J; Einstein AJ; Sedlar M; Li Q; Schmidt AM; Johnson LL
J Nucl Med; 2010 Jan; 51(1):92-7. PubMed ID: 20008983
[TBL] [Abstract][Full Text] [Related]
31. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.
Forbes JM; Yee LT; Thallas V; Lassila M; Candido R; Jandeleit-Dahm KA; Thomas MC; Burns WC; Deemer EK; Thorpe SR; Cooper ME; Allen TJ
Diabetes; 2004 Jul; 53(7):1813-23. PubMed ID: 15220206
[TBL] [Abstract][Full Text] [Related]
32. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.
Harja E; Bu DX; Hudson BI; Chang JS; Shen X; Hallam K; Kalea AZ; Lu Y; Rosario RH; Oruganti S; Nikolla Z; Belov D; Lalla E; Ramasamy R; Yan SF; Schmidt AM
J Clin Invest; 2008 Jan; 118(1):183-94. PubMed ID: 18079965
[TBL] [Abstract][Full Text] [Related]
33. Protection from diabetes-induced atherosclerosis and renal disease by D-carnosine-octylester: effects of early vs late inhibition of advanced glycation end-products in Apoe-null mice.
Menini S; Iacobini C; Ricci C; Blasetti Fantauzzi C; Pugliese G
Diabetologia; 2015 Apr; 58(4):845-53. PubMed ID: 25471794
[TBL] [Abstract][Full Text] [Related]
34. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.
Bucciarelli LG; Wendt T; Qu W; Lu Y; Lalla E; Rong LL; Goova MT; Moser B; Kislinger T; Lee DC; Kashyap Y; Stern DM; Schmidt AM
Circulation; 2002 Nov; 106(22):2827-35. PubMed ID: 12451010
[TBL] [Abstract][Full Text] [Related]
35. RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.
Daffu G; Shen X; Senatus L; Thiagarajan D; Abedini A; Hurtado Del Pozo C; Rosario R; Song F; Friedman RA; Ramasamy R; Schmidt AM
Diabetes; 2015 Dec; 64(12):4046-60. PubMed ID: 26253613
[TBL] [Abstract][Full Text] [Related]
36. Reactive Oxygen Species Can Provide Atheroprotection via NOX4-Dependent Inhibition of Inflammation and Vascular Remodeling.
Gray SP; Di Marco E; Kennedy K; Chew P; Okabe J; El-Osta A; Calkin AC; Biessen EA; Touyz RM; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):295-307. PubMed ID: 26715682
[TBL] [Abstract][Full Text] [Related]
37. AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice.
Gao X; Zhang H; Schmidt AM; Zhang C
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H491-8. PubMed ID: 18539754
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice.
Di Marco E; Gray SP; Chew P; Kennedy K; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
Clin Sci (Lond); 2016 Aug; 130(15):1363-74. PubMed ID: 27190136
[TBL] [Abstract][Full Text] [Related]
39. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
Schmidt AM; Yan SD; Wautier JL; Stern D
Circ Res; 1999 Mar; 84(5):489-97. PubMed ID: 10082470
[TBL] [Abstract][Full Text] [Related]
40. Dendritic cell-mediated chronic low-grade inflammation is regulated by the RAGE-TLR4-PKCĪ²
Zhao L; Li Y; Xu T; Lv Q; Bi X; Liu X; Fu G; Zou Y; Ge J; Chen Z; Zhang W
Mol Med; 2022 Jan; 28(1):4. PubMed ID: 35062863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
